APA (7th ed.) Citation

Ichikawa, T., Miyaaki, H., Miuma, S., Taura, N., Motoyoshi, Y., Akahoshi, H., . . . Nakao, K. (2019). Changes in serum LDL, PCSK9 and microRNA-122 in patients with chronic HCV infection receiving Daclatasvir/Asunaprevir. Biomedical Reports, 10(3), 1.

Chicago Style (17th ed.) Citation

Ichikawa, Tatsuki, et al. "Changes in Serum LDL, PCSK9 and MicroRNA-122 in Patients with Chronic HCV Infection Receiving Daclatasvir/Asunaprevir." Biomedical Reports 10, no. 3 (2019): 1.

MLA (9th ed.) Citation

Ichikawa, Tatsuki, et al. "Changes in Serum LDL, PCSK9 and MicroRNA-122 in Patients with Chronic HCV Infection Receiving Daclatasvir/Asunaprevir." Biomedical Reports, vol. 10, no. 3, 2019, p. 1.